Brian D. Smith

The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer customer relations and increasingly tailored health services.

Evolutionary Threats and Opportunities

The Future of Pharma

Randall R. Reeves

Toshio Kasuya

This compilation brings together current information on the status of Asian freshwater cetacean populations, the factors that have caused their recent declines, and what can be done to improve their chances for survival. Includes papers on water development issues, the Yangtze River Dolphin (Baiji), the Ganges River Dolphin (Susu), and porpoises. In the final section, five papers address methods of studying freshwater cetaceans.

Biology and Conservation of Freshwater Cetaceans in Asia

The healthcare professionals who save and extend our lives are helpless without the medicines and technologies that have revolutionised medical care. But the industry that invents, makes and provides these indispensable tools is transforming under the pressure of ageing populations, globalisation and revolutions in biological and information technology. How this industry adapts and evolves is vitally important to every one of us. This book looks inside the heads and hearts of the people who lead the global pharmaceutical and medical technology industry. It describes how they make sense of their markets and the wider life sciences economy. It reveals what they have learned about how to lead large, complex organisations to compete in dynamic, global markets. Leadership in the Life Sciences is essential reading for anyone working in or with the pharmaceutical and medical technology industry and its halo of supporting companies. Written as ten succinct lessons, it gives the reader unique insight into what the industry’s leaders are thinking. Covering topics from leadership to organisational culture, from change management to digital disruption and from competitive strategy to value-creation, each chapter distils the accumulated wisdom of those who lead the complex and turbulent life sciences industry.

Brian D. Smith

Books

Your next favorite book is out there